vs

Side-by-side financial comparison of NUSCALE POWER Corp (SMR) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.

NUSCALE POWER Corp is the larger business by last-quarter revenue ($8.2M vs $4.9M, roughly 1.7× Sensus Healthcare, Inc.). Sensus Healthcare, Inc. runs the higher net margin — -64.1% vs -3316.2%, a 3252.1% gap on every dollar of revenue. On growth, NUSCALE POWER Corp posted the faster year-over-year revenue change (1635.2% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-199.9M). Over the past eight quarters, NUSCALE POWER Corp's revenue compounded faster (22.4% CAGR vs -31.9%).

NuScale Power Corporation is a publicly traded American company that designs and markets small modular reactors (SMRs). It is headquartered in Tigard, Oregon. The company's VOYGR power plant, which uses 50 MWe modules and scales to 12 modules, was the first SMR to be certified by the US Nuclear Regulatory Commission (NRC) (2022). The newer 77 MWe module designs, known as the VOYGR-4 and VOYGR-6, were submitted for NRC review on January 1, 2023, and approved May 29, 2025. NuScale is now seekin...

Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.

SMR vs SRTS — Head-to-Head

Bigger by revenue
SMR
SMR
1.7× larger
SMR
$8.2M
$4.9M
SRTS
Growing faster (revenue YoY)
SMR
SMR
+1697.4% gap
SMR
1635.2%
-62.2%
SRTS
Higher net margin
SRTS
SRTS
3252.1% more per $
SRTS
-64.1%
-3316.2%
SMR
More free cash flow
SRTS
SRTS
$197.5M more FCF
SRTS
$-2.4M
$-199.9M
SMR
Faster 2-yr revenue CAGR
SMR
SMR
Annualised
SMR
22.4%
-31.9%
SRTS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
SMR
SMR
SRTS
SRTS
Revenue
$8.2M
$4.9M
Net Profit
$-273.3M
$-3.2M
Gross Margin
32.9%
38.4%
Operating Margin
-6532.9%
-63.8%
Net Margin
-3316.2%
-64.1%
Revenue YoY
1635.2%
-62.2%
Net Profit YoY
-1465.5%
-304.9%
EPS (diluted)
$-1.85
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SMR
SMR
SRTS
SRTS
Q4 25
$4.9M
Q3 25
$8.2M
$6.9M
Q2 25
$8.1M
$7.3M
Q1 25
$13.4M
$8.3M
Q4 24
$34.2M
$13.1M
Q3 24
$8.8M
Q2 24
$9.2M
Q1 24
$10.7M
Net Profit
SMR
SMR
SRTS
SRTS
Q4 25
$-3.2M
Q3 25
$-273.3M
$-943.0K
Q2 25
$-17.6M
$-1.0M
Q1 25
$-14.0M
$-2.6M
Q4 24
$-75.0M
$1.5M
Q3 24
$1.2M
Q2 24
$1.6M
Q1 24
$2.3M
Gross Margin
SMR
SMR
SRTS
SRTS
Q4 25
38.4%
Q3 25
32.9%
39.4%
Q2 25
22.1%
39.7%
Q1 25
52.4%
52.2%
Q4 24
91.1%
54.4%
Q3 24
59.3%
Q2 24
58.7%
Q1 24
62.5%
Operating Margin
SMR
SMR
SRTS
SRTS
Q4 25
-63.8%
Q3 25
-6532.9%
-37.3%
Q2 25
-534.9%
-26.6%
Q1 25
-264.1%
-31.7%
Q4 24
-34.6%
13.2%
Q3 24
16.9%
Q2 24
21.5%
Q1 24
27.1%
Net Margin
SMR
SMR
SRTS
SRTS
Q4 25
-64.1%
Q3 25
-3316.2%
-13.7%
Q2 25
-219.0%
-14.2%
Q1 25
-104.7%
-30.8%
Q4 24
-219.1%
11.8%
Q3 24
13.7%
Q2 24
17.4%
Q1 24
21.3%
EPS (diluted)
SMR
SMR
SRTS
SRTS
Q4 25
$-0.19
Q3 25
$-1.85
$-0.06
Q2 25
$-0.13
$-0.06
Q1 25
$-0.11
$-0.16
Q4 24
$-0.77
$0.10
Q3 24
$0.07
Q2 24
$0.10
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SMR
SMR
SRTS
SRTS
Cash + ST InvestmentsLiquidity on hand
$691.8M
$22.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$828.7M
$48.1M
Total Assets
$883.1M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SMR
SMR
SRTS
SRTS
Q4 25
$22.1M
Q3 25
$691.8M
$24.5M
Q2 25
$420.7M
$22.2M
Q1 25
$521.4M
$19.1M
Q4 24
$441.6M
$22.1M
Q3 24
$22.6M
Q2 24
$19.0M
Q1 24
$14.7M
Stockholders' Equity
SMR
SMR
SRTS
SRTS
Q4 25
$48.1M
Q3 25
$828.7M
$51.2M
Q2 25
$692.9M
$52.1M
Q1 25
$704.0M
$53.0M
Q4 24
$618.7M
$55.8M
Q3 24
$54.1M
Q2 24
$52.9M
Q1 24
$51.2M
Total Assets
SMR
SMR
SRTS
SRTS
Q4 25
$53.0M
Q3 25
$883.1M
$58.3M
Q2 25
$606.5M
$58.9M
Q1 25
$618.1M
$60.2M
Q4 24
$544.7M
$62.2M
Q3 24
$59.9M
Q2 24
$58.2M
Q1 24
$57.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SMR
SMR
SRTS
SRTS
Operating Cash FlowLast quarter
$-199.8M
$-2.2M
Free Cash FlowOCF − Capex
$-199.9M
$-2.4M
FCF MarginFCF / Revenue
-2425.1%
-47.9%
Capex IntensityCapex / Revenue
0.9%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$332.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SMR
SMR
SRTS
SRTS
Q4 25
$-2.2M
Q3 25
$-199.8M
$2.3M
Q2 25
$-33.3M
$3.1M
Q1 25
$-22.8M
$-2.7M
Q4 24
$-26.4M
$-827.0K
Q3 24
$4.0M
Q2 24
$4.2M
Q1 24
$-8.2M
Free Cash Flow
SMR
SMR
SRTS
SRTS
Q4 25
$-2.4M
Q3 25
$-199.9M
$2.3M
Q2 25
$3.1M
Q1 25
$-22.9M
$-2.7M
Q4 24
$-26.5M
$-1.1M
Q3 24
$3.6M
Q2 24
$4.2M
Q1 24
$-8.4M
FCF Margin
SMR
SMR
SRTS
SRTS
Q4 25
-47.9%
Q3 25
-2425.1%
33.3%
Q2 25
42.2%
Q1 25
-170.9%
-32.2%
Q4 24
-77.3%
-8.6%
Q3 24
40.9%
Q2 24
45.8%
Q1 24
-79.0%
Capex Intensity
SMR
SMR
SRTS
SRTS
Q4 25
3.2%
Q3 25
0.9%
0.1%
Q2 25
0.4%
Q1 25
0.5%
0.1%
Q4 24
0.1%
2.3%
Q3 24
3.8%
Q2 24
0.0%
Q1 24
2.2%
Cash Conversion
SMR
SMR
SRTS
SRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.53×
Q3 24
3.25×
Q2 24
2.62×
Q1 24
-3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SMR
SMR

Power Plant And NPM Engineering Design And Licensing Services And Fees$8.0M97%
Other$208.0K3%

SRTS
SRTS

Products$2.8M57%
Other$2.1M43%

Related Comparisons